MabCure, Inc. (MBCI)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Mar 4, 2026
100.00%
Market Cap 156.22K
Revenue (ttm) 500.00K
Net Income (ttm) -12.26M
Shares Out 781.09M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,640
Average Volume 58,497
Open 0.0002
Previous Close n/a
Day's Range 0.0002 - 0.0002
52-Week Range 0.0000 - 0.0003
Beta 12.38
RSI 60.90
Earnings Date n/a

About MabCure

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains... [Read more]

Industry Solar
Sector Technology
Founded 2006
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol MBCI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.